IT Versione italiana

video » MeRes–1 Study on thin-strut sirolimus-eluting bioresorbable scaffold



related diseases: Ischemic heart disease -
congress: Euro PCR 2019

MeRes–1 Study. Three-year clinical and two-year multimodality imaging outcomes of thin-strut sirolimus-eluting bioresorbable vascular scaffold in patients with coronary artery disease




Cookies helps us to provide our services. Using these services , you agree to use of cookies on our part. OK